Drug Name: | Cycloserine (68-41-7) |
---|---|
PubChem ID: | 6234 |
SMILES: | C1[C@H](C(=O)NO1)N |
InchiKey: | DYDCUQKUCUHJBH-UWTATZPHSA-N |
Therapeutic Category: | Anti-Bacterial Agents, Anti-Infective Agents, Antibiotics, Antimetabolites, Antitubercular Agents, Noxae, Renal Agents |
Molecular Weight (dalton) | : | 102.093 |
LogP | : | -1.6249 |
Ring Count | : | 0 |
Hydrogen Bond Acceptor Count | : | 3 |
Hydrogen Bond Donor Count | : | 2 |
Total Polar Surface Area | : | 64.35 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Ethionamide (536-33-4) | Neurotoxicity | Additive | Not known | Reversible pellagra-like encephalopathy with ethionamide and cycloserine |
Isoniazid (54-85-3) | Increased Adverse Cns Effects | Additive | Not known | Serum levels, urinary excretion, and side-effects of cycloserine in the presence of isoniazid and p-aminosalicylic acid |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|---|---|
High fat meals | Decrease The Serum Concentration | Food-Drug Interactions |
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category